John Lipani, MD

Article

COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed

Author:

John Lipani, MD

Unless a clear cause-and-effect relationship can be proved between COX-2 inhibitors and cardiovascular events, we should go on using these drugs.

• Read More